ArticleCancers2025
Exploring the Priorities of Patients with Early Breast Cancer in the United States: A Qualitative Interview Study and Patient-Informed Conceptual Disease Model.
Ashley Duenas, Zulikhat Segunmaru, Deborah Collyar, Debora Denardi, Claudine Clucas, Klaudia Kornalska, Qixin Li, Chintal H Shah, Paul Swinburn, Mariana Chavez-MacGregor and 1 more
Abstract read
In one paragraphArticle in Cancers, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
11 authors.
Ashley DuenasPPD Evidera Patient Centered Research, Thermo Fisher Scientific, London W6 8DN, UK.
Zulikhat SegunmaruOncology Outcomes Research (O2R), Evidence Generation, Publications, and Partnerships, Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA.
Debora DenardiFORCE-Facing Our Risk of Cancer Empowered, Tampa, FL 33160, USA.
Claudine ClucasPPD Evidera Patient Centered Research, Thermo Fisher Scientific, London W6 8DN, UK.
Klaudia KornalskaPPD Evidera Patient Centered Research, Thermo Fisher Scientific, London W6 8DN, UK.
Qixin LiOncology Outcomes Research (O2R), Evidence Generation, Publications, and Partnerships, Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA.ORCID 0009-0007-4522-1594 Chintal H ShahOncology Outcomes Research (O2R), Evidence Generation, Publications, and Partnerships, Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA.ORCID 0000-0002-0225-507X Paul SwinburnPPD Evidera Patient Centered Research, Thermo Fisher Scientific, London W6 8DN, UK.
Mariana Chavez-MacGregorDepartment of Health Services Research, The University of Texas MD Anderson Cancer Center, Houston, TX 77030, USA.ORCID 0000-0002-7189-0763 Xiaoqing XuOncology Outcomes Research (O2R), Evidence Generation, Publications, and Partnerships, Global Medical Affairs, Oncology Business Unit, AstraZeneca, Gaithersburg, MD 20878, USA.
Funding
AstraZeneca (US) N/A
6 · The paper itselfAbstract
PubMed holds no abstract for this paper.
Indexed as
breast neoplasmspatient-centered researchpatient engagementpatient experiencequalitative researchquality of life
Identifiers
PMID41228312
PMCPMC12607628
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390